{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:47:36Z","timestamp":1770706056928,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00259-011-1740-1","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T14:41:18Z","timestamp":1297694478000},"page":"996-1008","source":"Crossref","is-referenced-by-count":36,"title":["PET\/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Shu-Hang","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Chieh","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ta","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Tung-Chieh Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheung-Fat","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Hsing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00234-008-0426-2","volume":"50","author":"SH Ng","year":"2008","unstructured":"Ng SH, Chan SC, Liao CT, Chang JT, Ko SF, Wang HM, et al. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT. Neuroradiology 2008;50:969\u201379.","journal-title":"Neuroradiology"},{"key":"1740_CR2","first-page":"134","volume":"44","author":"C Mohadjer","year":"1996","unstructured":"Mohadjer C, Dietz A, Maier H, Weidauer H. Distant metastasis and incidence of second carcinomas in patients with oropharyngeal and hypopharyngeal carcinomas. HNO 1996;44:134\u20139.","journal-title":"HNO"},{"key":"1740_CR3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2001.19.5.1358","volume":"19","author":"HS Erkal","year":"2001","unstructured":"Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 2001;19:1358\u201362.","journal-title":"J Clin Oncol"},{"key":"1740_CR4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1200\/JCO.1994.12.5.946","volume":"12","author":"SG Urba","year":"1994","unstructured":"Urba SG, Forastiere AA, Wolf GT, Esclamado RM, McLaughlin PW, Thornton AF. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 1994;12:946\u201353.","journal-title":"J Clin Oncol"},{"key":"1740_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1995.13.3.671","volume":"13","author":"DG Pfister","year":"1995","unstructured":"Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, et al. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol 1995;13:671\u201380.","journal-title":"J Clin Oncol"},{"key":"1740_CR6","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1200\/JCO.2002.11.026","volume":"20","author":"M Machtay","year":"2002","unstructured":"Machtay M, Rosenthal DI, Hershock D, Jones H, Williamson S, Greenberg MJ, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. J Clin Oncol 2002;20:3964\u201371.","journal-title":"J Clin Oncol"},{"key":"1740_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2005.04.017","volume":"23","author":"SG Urba","year":"2005","unstructured":"Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 2005;23:88\u201395.","journal-title":"J Clin Oncol"},{"key":"1740_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/RMR.0b013e3181570c3f","volume":"18","author":"ND Wycliffe","year":"2007","unstructured":"Wycliffe ND, Grover RS, Kim PD, Simental Jr A. Hypopharyngeal cancer. Top Magn Reson Imaging 2007;18:243\u201358.","journal-title":"Top Magn Reson Imaging"},{"key":"1740_CR9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00259-003-1408-6","volume":"31","author":"K Kubota","year":"2004","unstructured":"Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI\/CT. Eur J Nucl Med Mol Imaging 2004;31:590\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1740_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1536-1632(03)00102-1","volume":"5","author":"BM Klabbers","year":"2003","unstructured":"Klabbers BM, Lammertsma AA, Slotman BJ. The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 2003;5:257\u201370.","journal-title":"Mol Imaging Biol"},{"key":"1740_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.oraloncology.2008.10.015","volume":"45","author":"R Bree de","year":"2009","unstructured":"de Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 2009;45:386\u201393.","journal-title":"Oral Oncol"},{"key":"1740_CR12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s002590100554","volume":"28","author":"E Kresnik","year":"2001","unstructured":"Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, Heinisch M, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001;28:816\u201321.","journal-title":"Eur J Nucl Med"},{"key":"1740_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1148\/radiol.2352040134","volume":"235","author":"BF Branstetter","year":"2005","unstructured":"Branstetter BF, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, et al. Head and neck malignancy: is PET\/CT more accurate than PET or CT alone? Radiology 2005;235:580\u20136.","journal-title":"Radiology"},{"key":"1740_CR14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00259-008-0918-7","volume":"36","author":"SH Ng","year":"2009","unstructured":"Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET\/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 2009;36:12\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1740_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.2311030271","volume":"231","author":"H Sch\u00f6der","year":"2004","unstructured":"Sch\u00f6der H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET\/CT image fusion. Radiology 2004;231:65\u201372.","journal-title":"Radiology"},{"key":"1740_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hed.20504","volume":"29","author":"HS Jeong","year":"2007","unstructured":"Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J, et al. Use of integrated 18F-FDG PET\/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203\u201310.","journal-title":"Head Neck"},{"key":"1740_CR17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s00330-005-2678-0","volume":"15","author":"F Schick","year":"2005","unstructured":"Schick F. Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 2005;15:946\u201359.","journal-title":"Eur Radiol"},{"key":"1740_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1148\/radiol.2331030777","volume":"233","author":"TC Lauenstein","year":"2004","unstructured":"Lauenstein TC, Goehde SC, Herborn CU, Goyen M, Oberhoff C, Debatin JF, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004;233:139\u201348.","journal-title":"Radiology"},{"key":"1740_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejrad.2007.11.006","volume":"65","author":"WA Willinek","year":"2008","unstructured":"Willinek WA, Schild HH. Clinical advantages of 3.0\u00a0T MRI over 1.5\u00a0T. Eur J Radiol 2008;65:2\u201314.","journal-title":"Eur J Radiol"},{"key":"1740_CR20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00330-008-1289-y","volume":"19","author":"GP Schmidt","year":"2009","unstructured":"Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, et al. Whole-body MRI at 1.5\u00a0T and 3\u00a0T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009;19:1366\u201378.","journal-title":"Eur Radiol"},{"key":"1740_CR21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.rli.0000262089.55618.18","volume":"42","author":"GP Schmidt","year":"2007","unstructured":"Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007;42:449\u201359.","journal-title":"Invest Radiol"},{"key":"1740_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiol.2463060881","volume":"246","author":"CK Kuhl","year":"2008","unstructured":"Kuhl CK, Tr\u00e4ber F, Schild HH. Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part I. Technical considerations and clinical applications. Radiology 2008;246:675\u201396.","journal-title":"Radiology"},{"key":"1740_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejrad.2007.10.021","volume":"65","author":"GP Schmidt","year":"2008","unstructured":"Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3\u00a0T compared to FDG-PET-CT. Eur J Radiol 2008;65:47\u201358.","journal-title":"Eur J Radiol"},{"key":"1740_CR24","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00330-010-1784-9","volume":"20","author":"SH Ng","year":"2010","unstructured":"Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, et al. Comprehensive imaging of residual\/recurrent nasopharyngeal carcinoma using whole-body MRI at 3\u00a0T compared with FDG-PET-CT. Eur Radiol 2010;20:2229\u201340.","journal-title":"Eur Radiol"},{"key":"1740_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N","volume":"22","author":"AD King","year":"2000","unstructured":"King AD, Ahuja AT, Leung SF, Lam WW, Teo P, Chan YL, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000;22:275\u201381.","journal-title":"Head Neck"},{"key":"1740_CR26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.0.CO;2-#","volume":"19","author":"WW Lam","year":"1997","unstructured":"Lam WW, Chan YL, Leung SF, Metreweli C. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck 1997;19:176\u201381.","journal-title":"Head Neck"},{"key":"1740_CR27","first-page":"1073","volume":"31","author":"SH Ng","year":"2004","unstructured":"Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, et al. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging 2004;31:1073\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1740_CR28","first-page":"1189","volume":"19","author":"NJ Fischbein","year":"1998","unstructured":"Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual\/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189\u201396.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1740_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2273.1997.00852.x","volume":"22","author":"WL Wong","year":"1997","unstructured":"Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 1997;22:209\u201314.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"1740_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiology.200.1.8657901","volume":"200","author":"Y Anzai","year":"1996","unstructured":"Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135\u201341.","journal-title":"Radiology"},{"key":"1740_CR31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-4486.2008.01688.x","volume":"33","author":"MG Isles","year":"2008","unstructured":"Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008;33:210\u201322.","journal-title":"Clin Otolaryngol"},{"key":"1740_CR32","doi-asserted-by":"crossref","unstructured":"Zimmer LA, Snyderman C, Fukui MB, Blodgett T, McCook B, Townsend DW, et al. The use of combined PET\/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J 2005;84:104, 106, 108\u201310.","DOI":"10.1177\/014556130508400215"},{"key":"1740_CR33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hed.20362","volume":"28","author":"AY Chen","year":"2006","unstructured":"Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 2006;28:487\u201395.","journal-title":"Head Neck"},{"key":"1740_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0720-048X(02)00061-X","volume":"44","author":"SH Ng","year":"2002","unstructured":"Ng SH, Liu HM, Ko SF, Hao SP, Chong VF. Posttreatment imaging of the nasopharynx. Eur J Radiol 2002;44:82\u201395.","journal-title":"Eur J Radiol"},{"key":"1740_CR35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.MLG.0000215176.98582.A9","volume":"116","author":"CG Gourin","year":"2006","unstructured":"Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006;116:705\u201310.","journal-title":"Laryngoscope"},{"key":"1740_CR36","first-page":"119","volume":"29","author":"SH Ng","year":"2006","unstructured":"Ng SH, Ko SF, Toh CH, Chen YL. Imaging of neck metastases. Chang Gung Med J 2006;29:119\u201329.","journal-title":"Chang Gung Med J"},{"key":"1740_CR37","first-page":"1136","volume":"46","author":"SH Ng","year":"2005","unstructured":"Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18F-FDG PET and CT\/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136\u201343.","journal-title":"J Nucl Med"},{"key":"1740_CR38","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1200\/JCO.2006.05.7349","volume":"24","author":"SH Ng","year":"2006","unstructured":"Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371\u20136.","journal-title":"J Clin Oncol"},{"key":"1740_CR39","first-page":"237","volume":"76","author":"JA Woolgar","year":"1994","unstructured":"Woolgar JA, Vaughan ED, Scott J, Brown JS. Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma. Ann R Coll Surg Engl 1994;76:237\u201344.","journal-title":"Ann R Coll Surg Engl"},{"key":"1740_CR40","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s00330-009-1504-5","volume":"19","author":"SH Ng","year":"2009","unstructured":"Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT. Eur Radiol 2009;19:2965\u201376.","journal-title":"Eur Radiol"},{"key":"1740_CR41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1148\/radiol.2482071822","volume":"248","author":"CA Yi","year":"2008","unstructured":"Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET\/CT versus 3.0-T whole-body MR imaging. Radiology 2008;248:632\u201342.","journal-title":"Radiology"},{"key":"1740_CR42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.rli.0000185878.61270.b0","volume":"40","author":"GP Schmidt","year":"2005","unstructured":"Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005;40:743\u201353.","journal-title":"Invest Radiol"},{"key":"1740_CR43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","volume":"43","author":"C Pfannenberg","year":"2007","unstructured":"Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007;43:557\u201364.","journal-title":"Eur J Cancer"},{"key":"1740_CR44","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1001\/jama.290.24.3199","volume":"290","author":"G Antoch","year":"2003","unstructured":"Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET\/CT and whole-body MRI for tumor staging in oncology. JAMA 2003;290:3199\u2013206.","journal-title":"JAMA"},{"key":"1740_CR45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/ajr.177.1.1770229","volume":"177","author":"HE Daldrup-Link","year":"2001","unstructured":"Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, J\u00fcrgens H, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001;177:229\u201336.","journal-title":"AJR Am J Roentgenol"},{"key":"1740_CR46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00330-006-0183-8","volume":"16","author":"GP Schmidt","year":"2006","unstructured":"Schmidt GP, Haug AR, Schoenberg SO, Reiser MF. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 2006;16:1216\u201325.","journal-title":"Eur Radiol"},{"key":"1740_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2214\/ajr.183.1.1830071","volume":"183","author":"FM Vogt","year":"2004","unstructured":"Vogt FM, Herborn CU, Hunold P, Lauenstein TC, Schr\u00f6der T, Debatin JF, et al. HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 2004;183:71\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"1740_CR48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jmri.21218","volume":"27","author":"BB Frericks","year":"2008","unstructured":"Frericks BB, Meyer BC, Martus P, Wendt M, Wolf KJ, Wacker F. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). J Magn Reson Imaging 2008;27:538\u201345.","journal-title":"J Magn Reson Imaging"},{"key":"1740_CR49","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2002.02.590","volume":"20","author":"RJ Wong","year":"2002","unstructured":"Wong RJ, Lin DT, Sch\u00f6der H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199\u2013208.","journal-title":"J Clin Oncol"},{"key":"1740_CR50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2967\/jnumed.108.055806","volume":"50","author":"R Abgral","year":"2009","unstructured":"Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, et al. Does 18F-FDG PET\/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009;50:24\u20139.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1740-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-011-1740-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1740-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T14:45:26Z","timestamp":1560005126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-011-1740-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s00259-011-1740-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}